BI
BIOGEN INC
BIIB· Health Care· BiotechnologyS&P 500
Close · 10/09/2026
215.43
1D
+2.23%52-week range
135.39 – 225.8
Volume
9,36,600.00
Price history
BIIB
11/08/2026 to 10/09/2026
O 209.92 H 216.70 L 208.93
1W-3.25%
1M+5.66%
3M+10.91%
6M+13.10%
1Y+50.02%
3Y-19.10%
5Y-36.31%
MAX-41.63%
Fundamentals
as of 10/09/2026- Market cap
- $31.81B
- Shares out
- 147.64M
- P/E (trailing)
- 23.18
- P/E (forward)
- 13.35
- EPS (trailing)
- 9.29
- Beta
- 0.17
- Profit margin
- 13.81%
- P/B
- 1.71
- Return on equity
- 7.36%
SEC financial statements
66 quarterly and 19 annual periods through 31/03/2026.
Details
- Ticker
- BIIB
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
12 filers · 2 on watchlist · 15 buys · 8 sells · ?: 9 · D: 6 · R: 8
- 18/08/2026Kevin HernWSellBiogen Inc. - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyBiogen Inc. - Common Stock$1,001–$15,000
- 02/06/2026Maria Elvira SalazarSellBiogen Inc. - Common Stock$15,001–$50,000
- 05/06/2026Gilbert CisnerosBuyBiogen Inc. - Common Stock$1,001–$15,000
- 12/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$1,001–$15,000
- 11/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$1,001–$15,000
- 11/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$50,001–$100,000
- 30/01/2026Gilbert CisnerosBuyBiogen Inc. - Common Stock$1,001–$15,000